[1] |
Gorlin RJ,Anderson RC,Blaw M. Multiple lentigenes syndrome[J]. Am J Dis Child, 1969, 117(6): 652-662.
|
[2] |
Gorlin RJ,Anderson RC,Moller JH. The Leopard (multiple lentigines) syndrome revisited[J]. Birth Defects Orig Artic Ser, 1971, 7(4): 110-115.
|
[3] |
Voron DA,Hatfield HH,Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature[J]. Am J Med, 1976, 60(3): 447-456.
|
[4] |
Digilio MC,Sarkozy A,de Zorzi A, et al. LEOPARD syndrome: clinical diagnosis in the first year of life[J]. Am J Med Genet A, 2006, 140(7): 740-746.
|
[5] |
Sarkozy A,Conti E,Digilio MC, et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome[J]. J Med Genet, 2004, 41(5): e68.
|
[6] |
Wang Y,Chen C,Wang DW. Leopard syndrome caused by heterozygous missense mutation of Tyr 279 Cys in the PTPN11 gene in a sporadic case of Chinese Han[J]. Int J Cardiol, 2014, 174(3): e101-e104.
|
[7] |
Osawa R,Akiyama M,Yamanaka Y, et al. A novel PTPN11 missense mutation in a patient with LEOPARD syndrome[J]. Br J Dermatol, 2009, 161(5): 1202-1204.
|
[8] |
Du-Thanh A,Cave H,Bessis D, et al. A novel PTPN11 gene mutation in a patient with LEOPARD Syndrome[J]. Arch Dermatol, 2007, 143(9): 1210-1211.
|
[9] |
Martinez-Quintana E,Rodriguez-Gonzalez F. LEOPARD syndrome: clinical features and gene mutations[J]. Mol Syndromol, 2012, 3(4): 145-157.
|
[10] |
Nishi E,Mizuno S,Nanjo Y, et al. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines[J]. Am J Med Genet A, 2015, 167A(2): 407-411.
|
[11] |
Yu ZH,Xu J,Walls CD, et al. Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations[J]. J Biol Chem, 2013, 288(15): 10472-10482.
|
[12] |
Motegi S,Yokoyama Y,Ogino S, et al. Pathogenesis of multiple lentigines in LEOPARD syndrome with PTPN11 gene mutation[J]. Acta Derm Venereol, 2015, 95(8): 978-984.
|
[13] |
Karbowniczek M,Spittle CS,Morrison T, et al. mTOR is activated in the majority of malignant melanomas[J]. J Invest Dermatol, 2008, 128(4): 980-987.
|
[14] |
Shaw RJ,Bardeesy N,Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling[J]. Cancer Cell, 2004, 6(1): 91-99.
|
[15] |
Marin TM,Keith K,Davies B, et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation[J]. J Clin Invest, 2011, 121(3): 1026-1043.
|
[16] |
Kratz CP,Rapisuwon S,Reed H, et al. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes[J]. Am J Med Genet C Semin Med Genet, 2011, 157C(2): 83-89.
|
[17] |
Banuls J,Alvarez-Chinchilla PJ,Lucas A, et al. Clinical, pathological and dermoscopic characteristics of cutaneous lesions in LEOPARD syndrome[J]. J Eur Acad Dermatol Venereol, 2018, 32(3): 100-101.
|
[18] |
Rodriguez-Bujaldon A,Vazquez-Bayo C,Jimenez-Puya R, et al. LEOPARD syndrome: what are cafe noir spots?[J]. Pediatr Dermatol, 2008, 25(4): 444-448.
|
[19] |
Keren B,Hadchouel A,Saba S, et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience[J]. J Med Genet, 2004, 41(11): e117.
|
[20] |
Coppin BD,Temple IK. Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis)[J]. J Med Genet, 1997, 34(7): 582-586.
|
[21] |
Sarkozy A,Digilio MC,Dallapiccola B. Leopard syndrome[J]. Orphanet J Rare Dis, 2008, 3(5): 13-21.
|
[22] |
Carcavilla A,Santome JL,Pinto I, et al. LEOPARD syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy[J]. Rev Esp Cardiol (Engl Ed), 2013, 66(5): 350-356.
|
[23] |
Jayaprasad N,Madhavan S. LEOPARD syndrome with patent ductus arteriosus and Hypertrophic cardiomyopathy[J]. J Assoc Physicians India, 2015, 63(5): 76-77.
|
[24] |
Limongelli G,Pacileo G,Marino B, et al. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome[J]. Am J Cardiol, 2007, 100(4): 736-741.
|
[25] |
Voron DA,Hatfield HH,Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature[J]. Am J Med, 1976, 60(3): 447-456.
|
[26] |
Digilio MC,Lepri F,Baban A et al. RASopathies: clinical diagnosis in the first year of life[J]. Mol Syndromol, 2011, 1(6): 282-289.
|
[27] |
Vermeire K,Wexler L,Vambutas A. The experience of bilateral cochlear implantation in a child with LEOPARD syndrome[J]. Int J Pediatr Otorhinolaryngol, 2016, 90(11): 125-127.
|
[28] |
Schrom T,Habermann A,Scherer H. Sensorineural hearing loss in LEOPARD syndrome[J]. HNO, 2006, 54(3): 202-206.
|
[29] |
Gunson TH,Hashim N,Sharpe GR. Generalized lentiginosis, short stature, and multiple cutaneous nodules--quiz case. LEOPARD syndrome (LS) associated with multiple granular cell tumors (GCTs)[J]. Arch Dermatol, 2010, 146(3): 337-342.
|
[30] |
Aragues IH,Dominguez MC,Blanco VP, et al. LEOPARD syndrome and multiple granular cell tumors: An underreported association?[J]. Indian J Dermatol Venereol Leprol, 2016, 82(1): 77-79.
|
[31] |
Ucar C,Calyskan U,Martini S, et al. Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive)[J].J Pediatr Hematol Oncol, 2006, 28(3): 123-125.
|
[32] |
Laux D,Kratz C,Sauerbrey A. Common acute lymphoblastic leukemia in a girl with genetically confirmed LEOPARD syndrome[J].J Pediatr Hematol Oncol, 2008, 30(8): 602-604.
|
[33] |
Seishima M,Mizutani Y,Shibuya Y, et al. Malignant melanoma in a woman with LEOPARD syndrome: identification of a germline PTPN11 mutation and a somatic BRAF mutation[J]. Br J Dermatol, 2007, 157(6): 1297-1299.
|
[34] |
Lodish MB,Stratakis CA. The differential diagnosis of familial lentiginosis syndromes[J]. Fam Cancer, 2011, 10(3): 481-490.
|
[35] |
Marsh DJ,Stratakis CA. Hamartoma and lentiginosis syndromes: clinical and molecular aspects[J]. Front Horm Res, 2001, 28: 167-213.
|
[36] |
Bauer AJ,Stratakis CA. The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis[J]. J Med Genet, 2005, 42(11): 801-810.
|
[37] |
Hosogi H,Nagayama S,Kawamura J, et al. Molecular insights into Peutz-Jeghers syndrome: two probands with a germline mutation of LKB1[J]. J Gastroenterol, 2008, 43(6): 492-497.
|
[38] |
Duan SX,Wang GH,Zhong J, et al. Peutz-Jeghers syndrome with intermittent upper intestinal obstruction: A case report and review of the literature[J]. Medicine (Baltimore), 2017, 96(17): e6538.
|
[39] |
Bertherat J. Carney complex (CNC)[J]. Orphanet J Rare Dis, 2006, 1(6): 21-26.
|
[40] |
Ko JH,Shih YC,Chiu CS, et al. Dermoscopic features in Laugier-Hunziker syndrome[J]. J Dermatol, 2011, 38(1): 87-90.
|
[41] |
Paul J,Harvey VM,Sbicca JA, et al. Laugier-Hunziker syndrome[J].Cutis, 2017, 100(3): E17-E19.
|
[42] |
Waite KA,Eng C. Protean PTEN: form and function[J]. Am J Hum Genet, 2002, 70(4): 829-844.
|
[43] |
Eng C. PTEN: one gene, many syndromes[J]. Hum Mutat, 2003, 22(3): 183-198.
|
[44] |
Tafazoli A,Eshraghi P,Koleti ZK, et al. Noonan syndrome - a new survey[J]. Arch Med Sci, 2017, 13(1): 215-222.
|
[45] |
Chu HS,Chung HS,Ko MH, et al. Syndromic hearing loss in association with PTPN11-Related disorder: the experience of cochlear implantation in a child with LEOPARD syndrome[J]. Clin Exp Otorhinolaryngol, 2013, 6(2): 99-102.
|